Preventing Stomach Cancer in Our Nation’s Heroes Act
Summary
H.R. 9531 is an early-stage procedural bill requiring the Secretary of Defense to produce a report on H. pylori testing for transitioning service members. It authorizes $0 in funding and imposes no mandates or procurement changes. There is no direct impact on any publicly traded defense contractor or healthcare company.
See which stocks are affected
Key takeaways, market implications, full AI analysis, and connected signals are available to HillSignal members.
Already have an account? Log in
Key Takeaways
- 1.H.R. 9531 is purely a report directive — no funding, no mandates, no procurement.
- 2.No publicly traded company experiences revenue, cost, or competitive changes from this bill in its current form.
- 3.Investors should ignore this bill until a funded testing program emerges — at which point $DGX and $LH would be primary beneficiaries.
Market Implications
No market implications. This bill does not change revenue, costs, or competitive dynamics for any publicly traded company. Investors monitoring defense or healthcare policy should classify this as noise until substantive funding legislation appears.
Full Analysis
On June 29, 2026, Rep. Smith (R-NJ) introduced H.R. 9531, the Preventing Stomach Cancer in Our Nation's Heroes Act. The bill directs the Secretary of Defense to submit a report to the Armed Services Committees within 180 days covering a plan, cost estimate, and feasibility study for implementing H. pylori testing using breath and stool methods during the transition to civilian life. The bill was referred to the House Committee on Armed Services, where it remains in early stage with no further action.
The money trail is clear: this is a report-only requirement. It authorizes zero dollars for testing or procurement — any future program would require separate legislation and appropriations. The bill only requires a study, not a program. No contracts or mandates flow from this action.
Convergence analysis: No related signals or procurement events were provided in the candidate context. The bill stands alone as a standalone study request with no real convergence to other federal actions.
Structural winners and losers: None at this stage. The bill creates no revenue opportunity or regulatory burden for any company. If a future testing program were funded, companies like $DGX (Quest Diagnostics) or $LH (LabCorp) with stool/breath-test laboratory capacity could see contracts, but that requires separate authorization and appropriation. No tickers meet the causal-chain confidence gate for this report-only bill.
Timeline: The earliest substantive action would be the report due 180 days after enactment — but enactment itself is distant. The bill is in committee with no hearings scheduled. Given it is a standalone study bill from a junior member, passage is uncertain and likely takes years.
Key Legislators
Connected Signals
Matched on shared policy language across AI analyses, with ticker & timing weight
RAUMA MARINE CONSTRUCTIONS OY: $1.1B Department of Homeland Security Contract
SPENCER CONSTRUCTION LLC: $1.1B Department of Homeland Security Contract
PANTEXAS DETERRENCE, LLC: $3.5B Department of Energy Contract
FISHER SAND & GRAVEL CO: $2.8B Department of Homeland Security Contract
SOUTHWEST VALLEY CONSTRUCTORS CO: $1.7B Department of Homeland Security Contract
RAUMA MARINE CONSTRUCTIONS OY: $1.1B Department of Homeland Security Contract
PANTEXAS DETERRENCE, LLC: $3.5B Department of Energy Contract
SPENCER CONSTRUCTION LLC: $1.1B Department of Homeland Security Contract
Related Presidential Actions
Executive orders & memoranda affecting the same sectors or companies
Advancing Regenerative Agriculture and Strengthening American Farm Resilience
This executive order directs the EPA, USDA, and HHS to prioritize registration of alternative pesticides, expedite cumulative exposure research, and maximize funding for a regenerative agriculture pilot program, while creating public-private partnerships to expand adoption of conservation farming practices. The order specifically instructs the EPA Administrator to speed up registration actions for substances that can replace older active ingredients, and requires HHS to issue a grand prize challenge for cumulative chemical exposure evaluation technologies.
Establishing an America First Arms Transfer Strategy
This executive order directs the Secretary of War, along with the Secretaries of State and Commerce, to create an 'America First Arms Transfer Strategy' that prioritizes foreign arms sales to boost U.S. defense industrial base capacity, streamline export processes, and enhance production of key weapons systems. It mandates a sales catalog of prioritized platforms within 120 days, forms a task force to improve coordination, and reforms congressional notification procedures for arms transfers.
Ushering in the Next Frontier of Quantum Innovation
This executive order updates the National Quantum Strategy and establishes a national effort (QC-ADDS) to develop a quantum computer for scientific discovery, with deployment at a Department of Energy facility. It directs multiple agencies to prioritize quantum sensing, networking, and supply chain initiatives, and mandates plans for commercial readiness and national security applications.
Free — no credit card
Get the next market-moving signal before the news does
HillSignal scores every Congressional bill, federal contract, and insider filing for market impact and emails you the high-conviction ones — free, no credit card.
Weekly digest — the congressional activity that actually moved markets that week, in plain English. Free, one email.
Free forever plan · No credit card · Unsubscribe in one click
Want the live terminal too? Create a free account →